Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Biosense Webster shares latest data on its pulsed field ablation system

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

Francisco Arabia, MD, Banner Health, explains trends in total artificial hearts (TAH) in advanced heart failure patients and what is coming in new technology.

Total artificial hearts: Exploring the future of heart transplant technology with a renowned surgeon

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.

Procyrion's Aortix percutaneous mechanical circulatory support (pMCS) device

Heart failure specialists raise $58M for new device designed to improve cardiac, renal function

Researchers are presently tracking the safety and effectiveness of the new device in patients with ADHF compared to diuretics alone. 

Targeting the left atrial posterior wall during pulsed field ablation fails to improve outcomes

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.

FDA approves first transcatheter tricuspid valve replacement device, the EVOQUE system from Edwards Lifesciences

Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device

The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation. 

Medtronic's PulseSelect Pulse Field Ablation (PFA) System

Real-world patients now being treated with Medtronic’s PFA system

Medtronic is celebrating the success of its PulseSelect pulsed field ablation product by highlighting its impact on heart patients around the world. 

Thumbnail

AI-powered risk score predicts how heart failure patients will respond to loop diuretics

New research out of Texas could go a long way toward improving care for patients with acute decompensated heart failure.

Thumbnail

FDA announces Class I recall of more than 250,000 chest drains over safety concerns

According to the FDA, using these devices without following manufacturer recommendations could lead to “serious injuries or death." 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.